HOME >> BIOLOGY >> NEWS
Deficits associated with prenatal alcohol exposure can be seen as early as infancy

  • Most of the research on prenatal alcohol exposure has been conducted with children.
  • A new study uses heart-rate data collected from six-month-old babies to examine the effects of alcohol consumption during pregnancy.
  • Even as early as infancy, slower processing speeds and arousal-regulation problems are apparent.

Most of the research on arousal and attention deficits caused by prenatal alcohol exposure has been conducted with children. An innovative new study, published in the March issue of Alcoholism: Clinical & Experimental Research, examines different components of attention through use of heart-rate data collected from six-month-old infants whose mothers drank during pregnancy. The findings indicate that slower processing speeds and arousal-regulation problems exist as early as infancy.

"The postnatal environment that children experience has a tremendous impact on children's cognitive status and attentional regulation skills," explained Julie A. Kable, assistant professor at Emory University School of Medicine and first author of the study. "Children of women who consume large amounts of alcohol during pregnancy and/or are substance abusers often experience family environments that do not support optimal development. As a result, when you examine older children it is often difficult to partition out the impact of the prenatal exposure with the impact of the postnatal environment. Assessments conducted closer in time to the insult provide a more accurate picture of the teratogenic effect."

"From a clinical point of view," added Sandra W. Jacobson, a professor in the department of psychiatry and behavioral neurosciences at Wayne State University School of Medicine, "tests such as the ones used in this study are important since it is critical to identify affected children as early in infancy as possible. Interventions are more likely to prove effective when implemented early in development and when sp
'"/>


14-Mar-2004


Page: 1 2 3 4

Related biology news :

1. Simian virus 40 not associated with non-Hodgkin lymphoma, study shows
2. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
3. Common therapy for HIV associated with cervical abnormality regression
4. Milk consumption and calcium intake associated with lower colorectal cancer risk
5. Severe depression associated with greater number of nerve cells in thalamus region of brain
6. Calcium supplements associated with decreased risk of large bowel polyps
7. NIH funds new Boston College-Boston University study of B-1a cell associated with leukemia
8. Variation of gene associated with decreased risk of heart attack and stroke
9. Scientists identify six genes associated with survival in diffuse large B cell lymphoma
10. Chlamydiae infection may be associated with ocular adnexal lymphoma
11. Surprises found in gene variation associated with schizophrenia

Post Your Comments:
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ... and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/24/2014)... MA (PRWEB) December 23, 2014 Earlier ... Dr. James L. Sherley, director of the Adult Stem ... on an often overlooked and under appreciated unique property ... Self-Renewal by Distributed Stem Cells: Misunderstood in the Past, ... message to congress participants. He gave the address ...
(Date:12/24/2014)... 2014 The report provides ... its definition, classification, application and industry overview. ... process, and product cost structure. Production is ... analysis also covers upstream raw materials, equipment, ... trend and proposals. In the end, the ...
(Date:12/24/2014)... 2014 China Biologic Products, Inc. (NASDAQ: ... fully integrated plasma-based biopharmaceutical company in ... subsidiary, Shandong Taibang Biological Products Co. Ltd., has ... China Food and Drug Administration (the "CFDA") for ... disclosed in the Company,s public filings, the CFDA ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
Cached News: